Literature DB >> 8409390

Germline and productive C epsilon gene expression during in vivo IgE responses.

G Thyphronitis1, I M Katona, W C Gause, F D Finkelman.   

Abstract

In vitro studies have established that Ig isotype switching typically involves deletion of CH genes that are located between VDJ and the CH gene that will be expressed, and is preceded by transcription of a germline (g) form of that CH gene. Increases in g epsilon transcript levels are induced by the cytokine IL-4, and always precede switching to IgE. To evaluate whether a similar relationship occurs in vivo, we examined IL-4 mRNA, g epsilon RNA, productive (p) epsilon mRNA, and serum IgE levels in two in vivo systems: one in which the injection of anti-IgD antibody induces mIgD+ B cells to switch to the expression of IgE and to secrete this isotype, and a second in which the injection of anti-IgE antibody stimulates IgE secretion by B cells that had been induced to express membrane IgE by earlier treatment with anti-IgD antibody. Increases in IL-4 transcript levels in anti-IgD-injected mice were followed within 24 h by increases in g epsilon RNA, and, one to two days later, by increased p epsilon mRNA and serum IgE levels. IL-4 antagonists blocked the g epsilon and p epsilon RNA and serum IgE responses in these mice, whereas the injection of otherwise untreated mice with IL-4 stimulated, within 24 h, a large increase in g epsilon RNA levels, followed 1-2 days later by a small increase in p epsilon mRNA. Injection of anti-IgD-primed mice with anti-IgE antibody also stimulated increases in IL-4, g epsilon and p epsilon RNA levels; however, the increases in IL-4 and g epsilon RNA were considerably smaller, and the increases in p epsilon mRNA and serum IgE considerably larger, than those observed in anti-IgD antibody-injected mice. IL-4 antagonists blocked the anti-IgE antibody-induced g epsilon RNA response, but not the p epsilon mRNA or serum IgE responses. Thus, IL-4 is required for the induction of g epsilon RNA in at least two in vivo systems, increased g epsilon RNA levels precede increases in p epsilon RNA levels in vivo as in vitro, and neither IL-4 nor g epsilon RNA is required to induce B cells that have already switched to IgE expression to differentiate into IgE-secreting cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409390

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Murine B cells regulate serum IgE levels in a CD23-dependent manner.

Authors:  Laurence E Cheng; Zhi-En Wang; Richard M Locksley
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

2.  Different role of IL-4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice.

Authors:  H Nagai; Y Ueda; T Ochi; Y Hirano; H Tanaka; N Inagaki; K Kawada
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.

Authors:  Takayuki Ota; Miyo Aoki-Ota; Bao Hoa Duong; David Nemazee
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

4.  CD8+ T cells inhibit immunoglobulin E synthesis in low responder SJL/J mice.

Authors:  M Yang; Y Cao; S S Mohapatra
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

5.  TRIF signaling is essential for TLR4-driven IgE class switching.

Authors:  Erin Janssen; Esra Ozcan; Kyriaki Liadaki; Haifa H Jabara; John Manis; Sumana Ullas; Shizuo Akira; Katherine A Fitzgerald; Douglas T Golenbock; Raif S Geha
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

6.  Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse.

Authors:  R A Morawetz; L Gabriele; L V Rizzo; N Noben-Trauth; R Kühn; K Rajewsky; W Müller; T M Doherty; F Finkelman; R L Coffman; H C Morse
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation.

Authors:  K M Toellner; A Gulbranson-Judge; D R Taylor; D M Sze; I C MacLennan
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.